Authors: KAKKAS I KARMIRIS T MALEKOU S BALTATHAKIS I GIGANTES S GIANNAKAKIS A PAGONIS M KARAKASIS D SKANDALIS A HARHALAKIS N NIKIFORAKIS E

Citation: I. Kakkas et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE (HD), Bone marrow transplantation, 21, 1998, pp. 571-571

Authors: KARAKASSIS D MALEKOU S GIANNAKAKI A SKANDALIS A HARHALAKIS N KAPSIMALIS V KARATZA M TZIOTZIOU I PAGONIS M KARMIRIS T NIKIFORAKIS N

Citation: D. Karakassis et al., AUTOLOGOUS TRANSPLANTATION WITH ACTIVATED MARROW, Bone marrow transplantation, 21, 1998, pp. 572-572

Authors: GIGANTES S DELIMPASI S MALEKOU S PAGONI M KARAKASIS D KARMIRIS TH BAKIRI M MITSOULI C SKANDALIS A HARHALAKIS N NIKIFORAKIS E

Citation: S. Gigantes et al., 4 CYCLES OF CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA AGED OVER 50 YEARS, Blood, 90(10), 1997, pp. 3824-3824

Authors: SKANDALIS A MALEKOU S POULAKIDAS E TSIONOS K KAKKAS J KATOPI D KARMIRIS T KARAKASIS D HARHALAKIS N NIKIFORAKIS E

Citation: A. Skandalis et al., BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY) AND ETOPOSIDE (VP-16) AS A PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3855-3855